- Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Praxis Precision Medicines Inc R&D Day Transcript
Good morning, everyone. It's a real pleasure to be here with all of you. The government is up, so you don't have to worry about that. So we can focus on our update for the R&D Day at Praxis. It's incredibly humbling to be here with some of the updates we are going to be showing today.
Before I get started, I just want to make sure we're going to be making forward-looking statements. Refer to our SEC website for some of them. And together with myself, we're going to be joined by some of our senior colleagues at Praxis, but also by Dr. Espay, an expert in movement disorders; by Dr. French, that requires no introduction, an expert on the epilepsy field as well.
The format of the meeting is going to be focused on some of the key topics that are relevant for us right now as a company and shortly thereafter, for each one of the sections we're going to have a Q&A. I more than encourage, I ask you to participate during the Q&A session. And I think we can have a very robust discussion with our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)